App-Quantinova.ai

Clinical risk factors for osteoporosis in type 1 diabetes

Ileana Duncea - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetic nephropathy

Ergocalciferol

Variability of anthropometric, echocardiographic and biochemical indices with comorbidity pathology essential hypertension and type 2 diabetes

A S Shalimova - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Essential arterial hypertension

Superoxide dismutase

Relationship between adiponectin and anthropometric parameters, insulin resistance and transaminase levels in patients with nonalcoholic fatty liver disease and type 2 diabetes

Anna Zhuravlyova - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Nonalcoholic fatty liver disease

N/A

Discrepancies between the glycosylated haemoglobin based criteria and glucose based criteria for diagnosis of diabetes and pre-diabetes

Siddha Bahadur Rana Magar - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Prediabetes

N/A

Association between +276 G>T polymorphism of the adiponectin gene (ADIPOQ) and insulin resistance in Ukrainian patients with type 2 diabetes mellitus (T2DM)

Nonna Kravchun - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

N/A

Vitamin D level in diabetic retinopathy

Muhammet Kazim Erol - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Microvascular complications of diabetes 1

Ergocalciferol

Gamma glutamyl transferase and C-reactive protein in type 2 Saudi diabetic patients in relation to management modality and components of metabolic syndrome

Maimoona Ahmed - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Metabolic syndrome

N/A

The prevalence of metabolic syndrome in patients with diagnosed type 2 diabetes

Erion Thengjilli - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Metabolic syndrome

N/A

Unvisible lipohypertrophy and diabetes compensation: is there link?

Ilya Davidenko - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

N/A

Glycoregulation during pregnancy

Aleksandar Djukic - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Gestational Diabetes

N/A

Optimal glycaemic control and a low rate of micro and macrovascular complications in patients with HNF1AMODY treated in a dedicated tertiary referral centre

Siobhán Bacon - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Peripheral artery disease

N/A

Dynamic thiol/disulfide homeostasis in patients with newly diagnosed type 2 diabetes mellitus

Ihsan Ates - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Type 2 diabetes mellitus

N/A

Correlation between fasting plasma glucose levels and HbA1c for diagnosis of prediabetes and diabetes: the 2011 Korea National Health and Nutrition Examination Survey

Jun Goo Kang - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Prediabetes

N/A

Higher glucose levels and prevalence of prediabetes in patients with autoimmune thyroiditis

Krystallenia Alexandraki - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Prediabetes

N/A

Effectiveness of A? classification of diabetes prone to ketosis in real clinical practice

Maria Porksheyan - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Hyperglycemia

Methadone hydrochloride

Mechanisms of development of carbohydrate metabolism disturbances in acromegalic patients depending on treatment

Irina V Trigolosova - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Acromegaly

Somatostatin

Contribution of glucose variability to HbA1c levels in patients with type 1 diabetes

Carla Batista - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

N/A

Prepregnancy care: an opportunity not to be missed

Andriy Danyliv - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Pregestational diabetes

FA-8

Concentrations of the vitamin D metabolite 1,25(OH)2D and its relationship to inflammatory and metabolic parameters in diabetes type 2

Ivana Prpic-Krizevac - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

Fibrinogen (IV)

10 years of improving outcomes for women with pre-gestational diabetes

Louise Carmody - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Pregestational diabetes

N/A

Filters

4759 Abstracts